EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report



Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report



Transplantation Proceedings 39(10): 3460-3462



Before the highly active antiretroviral therapy (HAART) era, kidney transplantation was not considered an option for patients infected with human immunodeficiency virus (HIV) because of its poor outcome. However, recent studies have demonstrated results comparable to those of recipients without HIV infections. They have shown that HIV-positive patients maintained on HAART mount an immune response. Immunosuppressive agents are chosen to minimize aggravation of HIV infection, bearing in mind the potential side effects of the combination of HAART and immunosuppressive drugs. Herein we have reported the case of a 43-year-old HIV- and hepatitis C virus-infected woman with preserved immune function who received a cadaveric kidney transplant and developed an acute humoral rejection, which was successfully treated with Rituximab.

(PDF same-day service: $19.90)

Accession: 055793749

Download citation: RISBibTeXText

PMID: 18089407

DOI: 10.1016/j.transproceed.2007.09.043



Related references

Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation?. Transplantation 88(1): 142; Author Reply 142-3, 2009

Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report. Transplantation Proceedings 40(1): 302-304, 2008

Reversible ileitis secondary to high dose intravenous immunoglobulin in adult kidney transplant patient treated for acute humoral rejection. Transplant International 24(12): E111-E114, 2012

Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation. World Journal of Gastroenterology 15(27): 3426-3430, 2009

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 73(6): 907-910, 2002

Treatment of acute humoral rejection in kidney transplantation with plasmapheresis. Transplantation Proceedings 27(1): 934-935, 1995

Predictors and outcomes of acute humoral rejection treated with plasmapheresis in heart transplant recipients. Journal of Heart & Lung Transplantation 22(1S): S169, January, 2003

Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 83(9): 1277-1280, 2007

Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 78(5): 772-774, 2004

Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplantation Proceedings 37(9): 3743-3745, 2006

Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases. Therapeutic Apheresis and Dialysis 7(6): 529-535, 2004

Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab. Transplantation Proceedings 36(10): 3164-3166, 2005

A truncated dose regimen of daclizumab for acute rejection prophylaxis in kidney transplant recipients A single center experience. Journal of the American Society of Nephrology 14(Abstracts Issue): 911A, November, 2003

A truncated-dose regimen of daclizumab for prevention of acute rejection in kidney transplant recipients: a single-center experience. Transplantation 78(10): 1560-1563, 2004

Acute humoral rejection in an ABO compatible combined liver-kidney transplant--the kidney is not always protected. American Journal of Transplantation 9(8): 1957-1960, 2010